机械循环系统能否支持在转诊中心对心脏性休克的综合方法,从而降低30天死亡率?
Marina Pieri1,2, Mario Iannaccone3, Francesco Burzotta4,5
1Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Frontiers in cardiovascular medicine
|January 31, 2025
概括
在心脏性休克 (CS) 中使用临时机械循环支持的综合方法,与预测风险相比,显著降低了观察到的30天死亡率. 这突显了先进的CS治疗策略的有效性.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 心血管器械 心血管器械
背景情况:
- 预测心脏性休克 (CS) 的死亡风险已经确立,但量化各种治疗干预措施的影响仍然具有挑战性.
- 心脏性冲击评分 (CSS) 提供了一个预测模型,但其在不同患者群体中的准确性需要验证.
- 评估包括机械循环支持在内的综合治疗策略的有效性对于改善CS结果至关重要.
研究的目的:
- 确定包括临时机械循环支持在内的心脏性休克 (CS) 综合治疗方法是否能降低30天死亡率.
- 为了比较使用Impella (一种心室内辅助装置) 治疗的CS患者观察到的30天死亡率与心脏性休克评分 (CSS) 预测的死亡率.
- 评估CSS在预测特定CS患者队列中的死亡率方面的诊断准确性.
主要方法:
- 在两个国家转诊中心连续接受Impella治疗的CS患者的回顾性分析.
- 使用CSS计算每个被纳入患者的30天预期死亡率.
- 观察到的30天死亡率与CSS预测的死亡率的比较以及使用ROC曲线分析评估CSS诊断准确度.
主要成果:
- 该研究包括170名CS患者 (平均年龄65±13岁,75.9%男性),急性心肌梗塞是主要原因 (71.1%).
- 观察到的30天死亡率 (41.5%) 显著低于CSS预测的死亡率 (51.8%,p < 0.001),特别是在CSS>4.4的患者中.
- 在这个人群中,CSS显示诊断准确性很差,曲线下的面积 (AUC) 为0.53 (p = 0.83).
结论:
- 与CSS预测相比,观察到的死亡率明显较低表明,包括临时机械循环支持在内的综合治疗方法可以改善关键CS的结果.
- 这种全面的策略,特别是在专门的转诊中心,在管理急性心脏病患者中发挥着至关重要的作用.
- 这些发现强调需要考虑先进的干预措施,如在多方面的CS治疗方案中考虑临时的机械循环支持.
相关概念视频
01:30Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...